Success Metrics

Clinical Success Rate
96.8%

Based on 60 completed trials

Completion Rate
97%(60/62)
Active Trials
8(10%)
Results Posted
23%(14 trials)
Terminated
2(2%)

Phase Distribution

Ph phase_3
9
11%
Ph not_applicable
5
6%
Ph phase_2
4
5%
Ph phase_4
21
26%
Ph phase_1
39
48%

Phase Distribution

39

Early Stage

4

Mid Stage

30

Late Stage

Phase Distribution78 total trials
Phase 1Safety & dosage
39(50.0%)
Phase 2Efficacy & side effects
4(5.1%)
Phase 3Large-scale testing
9(11.5%)
Phase 4Post-market surveillance
21(26.9%)
N/ANon-phased studies
5(6.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.8%

60 of 64 finished

Non-Completion Rate

6.3%

4 ended early

Currently Active

8

trials recruiting

Total Trials

81

all time

Status Distribution
Active(8)
Completed(60)
Terminated(4)
Other(9)

Detailed Status

Completed60
unknown9
Recruiting5
Active, not recruiting3
Withdrawn2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
81
Active
8
Success Rate
96.8%
Most Advanced
Phase 4

Trials by Phase

Phase 139 (50.0%)
Phase 24 (5.1%)
Phase 39 (11.5%)
Phase 421 (26.9%)
N/A5 (6.4%)

Trials by Status

recruiting56%
unknown911%
completed6074%
withdrawn22%
terminated22%
active_not_recruiting34%

Recent Activity

Clinical Trials (81)

Showing 20 of 81 trialsScroll for more
NCT07471867Phase 4

Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention

Recruiting
NCT07329972Phase 1

A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healthy Participants

Recruiting
NCT06916143Phase 1

Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach Acid

Active Not Recruiting
NCT06899061Phase 1

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Active Not Recruiting
NCT07284173Phase 1

A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults.

Active Not Recruiting
NCT05407675Phase 1

A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors

Completed
NCT07141381Phase 1

A Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN110755

Recruiting
NCT07122024Phase 4

Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment

Recruiting
NCT06417229Phase 1

Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants

Completed
NCT02475161Phase 1

A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy Participants

Completed
NCT05899829Phase 1

Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant

Completed
NCT06054464Phase 1

A Study to Investigate the Effects of Acid Reducing Agents on Pharmacokinetics of PC14586 in Healthy Participants

Completed
NCT05918822Phase 1

A Study of Maribavir Pediatric Formulation in Healthy Adult Participants

Completed
NCT06264440Phase 1

A Study to Assess the Potential for Gastric-pH Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump Inhibitor in Healthy Participants

Completed
NCT03320538Not Applicable

Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases

Completed
NCT03237741Phase 1

Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Participants

Completed
NCT05930119Phase 1

HMPL-453 Food Effect and PPI Study in Healthy Volunteer Study

Completed
NCT02135107Phase 3

A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients

Completed
NCT05718609Phase 4

Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection

Unknown
NCT05330858Phase 1

Relative Bioavailability of ESK-001 Tablet Versus Liquid in Healthy Participants

Completed

Drug Details

Intervention Type
DRUG
Total Trials
81